Skip to Content
Merck
All Photos(2)

Documents

HMHEMAG-34K

Millipore

MILLIPLEX® Human Metabolic Hormone Magnetic Bead Panel - Metabolism Multiplex Assay

The Human Metabolic Hormone Panel, using the Luminex xMAP technology, enables the simultaneous analysis of 13 protein biomarkers in human serum, plasma and cell/tissue culture samples.

Synonym(s):

human metabolic hormone immunoassay panel, luminex human metabolic hormone multiplex assay, millipore human metabolism multiplex kit

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12161503
eCl@ss:
32161000

species reactivity

human

manufacturer/tradename

Milliplex®

assay range

accuracy: 101%
(Glucagon)

accuracy: 102%
(Leptin)

accuracy: 103%
(GIP)

accuracy: 103%
(GLP-1 (Total))

accuracy: 105%
(Ghrelin (Active))

accuracy: 106%
(MCP-1)

accuracy: 97%
(TNFα)

accuracy: 99%
(C-Peptide)

sensitivity: 0.5 pg/mL
(MinDC+2SD; TNF?)

sensitivity: 1.1 pg/mL
(MinDC+2SD; GIP)

sensitivity: 13 pg/mL
(MinDC+2SD; IL-6)

sensitivity: 14 pg/mL
(MinDC+2SD; Ghrelin (Active))

sensitivity: 14 pg/mL
(MinDC+2SD; MCP-1)

sensitivity: 146 pg/mL
(MinDC+2SD; PYY)

sensitivity: 15 pg/mL
(MinDC+2SD; Amylin (Total))

sensitivity: 16 pg/mL
(MinDC+2SD; C-Peptide)

sensitivity: 16 pg/mL
(MinDC+2SD; Glucagon)

sensitivity: 160 pg/mL
(MinDC+2SD; Insulin)

sensitivity: 2.4 pg/mL
(MinDC+2SD; GLP-1 (Active))

sensitivity: 2.9 pg/mL
(MinDC+2SD; PP)

sensitivity: 28 pg/mL
(MinDC+2SD; Amylin (Active))

sensitivity: 64 pg/mL
(MinDC+2SD; Leptin)

sensitivity: 7.3 pg/mL
(MinDC+2SD; GLP-1 (Total))

standard curve range: 0.69-500 pg/mL
(TNFα)

standard curve range: 1.4-1,000 pg/mL
(GIP)

standard curve range: 13.7-10,000 pg/mL
(Amylin (Active))

standard curve range: 13.7-10,000 pg/mL
(Amylin (Total))

standard curve range: 13.7-10,000 pg/mL
(Ghrelin (Active))

standard curve range: 13.7-10,000 pg/mL
(Glucagon)

standard curve range: 13.7-10,000 pg/mL
(IL-6)

standard curve range: 13.7-10,000 pg/mL
(MCP-1)

standard curve range: 13.7-10,000 pg/mL
(PYY)

standard curve range: 137-100,000 pg/mL
(Insulin)

standard curve range: 137-100,000 pg/mL
(Leptin)

standard curve range: 2.7-2,000 pg/mL
(GLP-1 (Active))

standard curve range: 2.7-2,000 pg/mL
(GLP-1 (Total))

standard curve range: 2.7-2,000 pg/mL
(PP)

standard curve range: 27.4-20,000 pg/mL
(C-Peptide)

inter-assay cv: <15%
intra-assay cv: <10%
(C-Peptide)

inter-assay cv: <15%
intra-assay cv: <10%
(GIP)

inter-assay cv: <15%
intra-assay cv: <10%
(GLP-1 (Active))

inter-assay cv: <15%
intra-assay cv: <10%
(GLP-1 (Total))

inter-assay cv: <15%
intra-assay cv: <10%
(Ghrelin (Active))

inter-assay cv: <15%
intra-assay cv: <10%
(Glucagon)

inter-assay cv: <15%
intra-assay cv: <10%
(IL-6)

inter-assay cv: <15%
intra-assay cv: <10%
(Insulin)

inter-assay cv: <15%
intra-assay cv: <10%
(Leptin)

inter-assay cv: <15%
intra-assay cv: <10%
(MCP-1)

inter-assay cv: <15%
intra-assay cv: <10%
(PP)

inter-assay cv: <15%
intra-assay cv: <10%
(PYY)

inter-assay cv: <15%
intra-assay cv: <10%
(TNFα)

inter-assay cv: <20%
intra-assay cv: <10%
(Amylin (Active))

inter-assay cv: <20%
intra-assay cv: <10%
(Amylin (Total))

technique(s)

multiplexing: suitable

detection method

fluorometric (Luminex xMAP)

shipped in

wet ice

General description

Metabolic syndrome is a cluster of conditions, including increased blood pressure, elevated insulin levels, excess body fat around the waist, and abnormal cholesterol levels. Key features of metabolic syndrome include insulin resistance, glucose intolerance, hypertension, dyslipidemia, and central obesity—all of which are risk factors for atherosclerosis, coronary heart disease, type 2 diabetes, kidney disease, and even premature death. Adults with metabolic syndrome present a low-grade inflammation, whose link with obesity may be a production of pro- and anti-inflammatory factors. Consequently, research done in this area covers multi-faceted fields of cytokines, acute phase proteins, diabetes, and obesity related hormones, as well as other cardiovascular disease biomarkers.

The MILLIPLEX® Human Metabolic Hormone Panel is a 15 analyte, 13-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma and cell/tissue culture samples: Amylin (Active) or Amylin (Total), C-Peptide, Ghrelin (Active), GIP, GLP-1 (Active) or GLP-1 (Total), Glucagon, IL-6, Insulin, Leptin, MCP-1, PP, PYY, TNFα. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Metabolism

Application

  • Analytes: Amylin (Active), Amylin (Total), C-Peptide, Ghrelin (Active), GIP (Total), GLP-1 (Active), GLP-1 (Total), Glucagon, IL-6, Insulin, Leptin, MCP-1 (CCL2), Pancreatic Polypeptide (PP), PYY (Total), TNF-α
  • NOTE: The following analytes cannot be assayed simultaneously: Amylin (Active) & Amylin (Total); GLP-1 (Active) & GLP-1 (Total).
  • Recommended Sample Type: Human serum, plasma, and cell/tissue culture supernatants or lysates
  • Recommended Sample Dilution: 25 μL per well of undiluted serum or plasma; cell/tissue culture samples may be used undiluted or diluted with an appropriate control medium NOTE: The following analytes require the addition of protease inhibitors to serum or plasma samples (see sample collection and storage section in the protocol for details): GLP-1 (DPPIV inhibitor); Amylin (protease inhibitor cocktail); Glucagon (Aprotinin); Ghrelin (Active) (serine protease inhibitor).
  • Assay Run Time: Overnight (16-18 hours) at 2-8°C
  • Research Category: Metabolism
  • Research Subcategory: Metabolic Disorders

Features and Benefits

Design your multiplex kit by choosing available analytes within this panel.

Linkage

Replaces: HMHMAG-34K

Other Notes

Please contact Technical Service for linearity of dilution.
Please note: Amylin (Active) and Amylin (Total) cannot be plexed together. GLP-1 (Active) and GLP-1 (Total) cannot be plexed together.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Pictograms

Skull and crossbonesEnvironment

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

Storage Class Code

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Haitham Abdulla et al.
Endocrinology, diabetes & metabolism, 2(4), e00085-e00085 (2019-10-09)
The effect of substantive doses of essential amino acids (EAA) on incretin and insulin production, and the impact of age upon this effect, is ill-defined. A 15-g oral EAA drink was administered to young (N = 8; 26 ± 4.4 years) and older (N = 8; 69 ± 3.8 years)
Nathan C Winn et al.
Medicine and science in sports and exercise, 51(5), 995-1005 (2019-01-30)
Physical inactivity is associated with disruptions in glucose metabolism and energy balance, whereas energy restriction may blunt these adverse manifestations. During hypocaloric feeding, higher-protein intake maintains lean mass which is an important component of metabolic health. This study determined whether
Mary R Lee et al.
Neuropharmacology, 170, 107788-107788 (2019-09-27)
Both animal and human work suggests that the ghrelin system may be involved in the mechanisms that regulate the development and maintenance of alcohol use disorder. Previously, in a Phase 1b study, we tested pharmacological blockade of the growth hormone
Gabriella A Heruc et al.
American journal of physiology. Endocrinology and metabolism, 315(4), E565-E573 (2018-07-04)
Postprandial glucose is reduced in malnourished patients with anorexia nervosa (AN), but the mechanisms and duration for this remain unclear. We examined blood glucose, gastric emptying, and glucoregulatory hormone changes in malnourished patients with AN and during 2 wk of
Matthieu St-Jean et al.
PloS one, 12(5), e0177110-e0177110 (2017-05-12)
Hepatocyte nuclear factor 1 alpha (HNF1α) defects cause Mature Onset Diabetes of the Young type 3 (MODY3), characterized by defects in beta-cell insulin secretion. However, HNF1α is involved in many other metabolic pathways with relevance for monogenic or polygenic type

Related Content

Multiplex immunoassays save time and sample volume in metabolic syndrome research, providing comprehensive insights into related conditions.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service